A new study from the New England Journal of Medicine found that regardless of treatment methods, the risk of dying from early prostate cancer in the next 10 years is low and nearly identical. WSJ’s Lee Hawkins explains.

Subscribe to the WSJ channel here:
http://bit.ly/14Q81Xy

More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com

Follow WSJ on Facebook: http://www.facebook.com/wsjvideo
Follow WSJ on Google+: https://plus.google.com/+wsj/posts
Follow WSJ on Twitter: https://twitter.com/WSJvideo
Follow WSJ on Instagram: http://instagram.com/wsj
Follow WSJ on Pinterest: http://www.pinterest.com/wsj/
Don’t miss a WSJ video, subscribe here: http://bit.ly/14Q81Xy

More from the Wall Street Journal:
Visit WSJ.com: http://www.wsj.com
Visit the WSJ Video Center: https://wsj.com/video

On Facebook: https://www.facebook.com/pg/wsj/videos/
On Twitter: https://twitter.com/WSJ
On Snapchat: https://on.wsj.com/2ratjSM

Leave a Reply

Let us help fight cancer. Share your knowledge.

About

Latest news, views, insights and trends on cancer treatment, discovery and support

Navigation